Literature DB >> 15317890

Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate.

Theresa M Zucchero1, Margaret E Cooper, Brion S Maher, Sandra Daack-Hirsch, Buena Nepomuceno, Lucilene Ribeiro, Diana Caprau, Kaare Christensen, Yasushi Suzuki, Junichiro Machida, Nagato Natsume, Koh-Ichiro Yoshiura, Alexandre R Vieira, Ieda M Orioli, Eduardo E Castilla, Lina Moreno, Mauricio Arcos-Burgos, Andrew C Lidral, L Leigh Field, You-e Liu, Ajit Ray, Toby H Goldstein, Rebecca E Schultz, Min Shi, Marla K Johnson, Shinji Kondo, Brian C Schutte, Mary L Marazita, Jeffrey C Murray.   

Abstract

BACKGROUND: Cleft lip or palate (or the two in combination) is a common birth defect that results from a mixture of genetic and environmental factors. We searched for a specific genetic factor contributing to this complex trait by examining large numbers of affected patients and families and evaluating a specific candidate gene.
METHODS: We identified the gene that encodes interferon regulatory factor 6 (IRF6) as a candidate gene on the basis of its involvement in an autosomal dominant form of cleft lip and palate, Van der Woude's syndrome. A single-nucleotide polymorphism in this gene results in either a valine or an isoleucine at amino acid position 274 (V274I). We carried out transmission-disequilibrium testing for V274I in 8003 individual subjects in 1968 families derived from 10 populations with ancestry in Asia, Europe, and South America, haplotype and linkage analyses, and case-control analyses, and determined the risk of cleft lip or palate that is associated with genetic variation in IRF6.
RESULTS: Strong evidence of overtransmission of the valine (V) allele was found in the entire population data set (P<10(-9)); moreover, the results for some individual populations from South America and Asia were highly significant. Variation at IRF6 was responsible for 12 percent of the genetic contribution to cleft lip or palate and tripled the risk of recurrence in families that had already had one affected child.
CONCLUSIONS: DNA-sequence variants associated with IRF6 are major contributors to cleft lip, with or without cleft palate. The contribution of variants in single genes to cleft lip or palate is an important consideration in genetic counseling. Copyright 2004 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15317890     DOI: 10.1056/NEJMoa032909

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  216 in total

1.  Investigation of genetic factors underlying typical orofacial clefts: mutational screening and copy number variation.

Authors:  Milena Simioni; Tânia Kawasaki Araujo; Isabella Lopes Monlleo; Cláudia Vianna Maurer-Morelli; Vera Lúcia Gil-da-Silva-Lopes
Journal:  J Hum Genet       Date:  2014-11-13       Impact factor: 3.172

2.  The FGF and FGFR Gene Family and Risk of Cleft Lip With or Without Cleft Palate.

Authors:  Hong Wang; Tianxiao Zhang; Tao Wu; Jacqueline B Hetmanski; Ingo Ruczinski; Holger Schwender; Kung Yee Liang; Tanda Murray; M Daniele Fallin; Richard J Redett; Gerald V Raymond; Sheng-Chih Jin; Yah-Huei Wu Chou; Philip Kuo-Ting Chen; Vincent Yeow; Samuel S Chong; Felicia S H Cheah; Sun Ha Jee; Ethylin W Jabs; Alan F Scott; Terri H Beaty
Journal:  Cleft Palate Craniofac J       Date:  2011-11-10

3.  Ethnic heterogeneity of IRF6 AP-2a binding site promoter SNP association with nonsyndromic cleft lip and palate.

Authors:  Susan H Blanton; Amber Burt; Elizabeth Garcia; John B Mulliken; Samuel Stal; Jacqueline T Hecht
Journal:  Cleft Palate Craniofac J       Date:  2010-11

4.  Variants in genes that encode muscle contractile proteins influence risk for isolated clubfoot.

Authors:  Katelyn S Weymouth; Susan H Blanton; Michael J Bamshad; Anita E Beck; Christine Alvarez; Steve Richards; Christina A Gurnett; Matthew B Dobbs; Douglas Barnes; Laura E Mitchell; Jacqueline T Hecht
Journal:  Am J Med Genet A       Date:  2011-08-10       Impact factor: 2.802

Review 5.  Folic acid and orofacial clefts: a review of the evidence.

Authors:  G L Wehby; J C Murray
Journal:  Oral Dis       Date:  2010-01       Impact factor: 3.511

6.  A search for the gene(s) predisposing to idiopathic clubfoot.

Authors:  F R Dietz; W G Cole; L L Tosi; N C Carroll; R D Werner; D Comstock; J C Murray
Journal:  Clin Genet       Date:  2005-04       Impact factor: 4.438

7.  Proportion of Orofacial Clefts Attributable to Recognized Risk Factors.

Authors:  Janhavi R Raut; Regina M Simeone; Sarah C Tinker; Mark A Canfield; R Sue Day; A J Agopian
Journal:  Cleft Palate Craniofac J       Date:  2018-05-04

8.  Maternal transmission effects of the PAX genes among cleft case-parent trios from four populations.

Authors:  Jae Woong Sull; Kung-Yee Liang; Jacqueline B Hetmanski; Margaret Daniele Fallin; Roxanne G Ingersoll; Jiwan Park; Yah-Huei Wu-Chou; Philip K Chen; Samuel S Chong; Felicia Cheah; Vincent Yeow; Beyoung Yun Park; Sun Ha Jee; Ethylin W Jabs; Richard Redett; Alan F Scott; Terri H Beaty
Journal:  Eur J Hum Genet       Date:  2009-01-14       Impact factor: 4.246

9.  FOXE1 association with both isolated cleft lip with or without cleft palate, and isolated cleft palate.

Authors:  Lina M Moreno; Maria Adela Mansilla; Steve A Bullard; Margaret E Cooper; Tamara D Busch; Junichiro Machida; Marla K Johnson; David Brauer; Katherine Krahn; Sandy Daack-Hirsch; Jamie L'heureux; Consuelo Valencia-Ramirez; Dora Rivera; Ana Maria López; Manuel A Moreno; Anne Hing; Edward J Lammer; Marilyn Jones; Kaare Christensen; Rolv T Lie; Astanand Jugessur; Allen J Wilcox; Peter Chines; Elizabeth Pugh; Kim Doheny; Mauricio Arcos-Burgos; Mary L Marazita; Jeffrey C Murray; Andrew C Lidral
Journal:  Hum Mol Genet       Date:  2009-09-24       Impact factor: 6.150

10.  Autoantibodies to folate receptor alpha during early pregnancy and risk of oral clefts in Denmark.

Authors:  Camilla Bille; Dorthe Almind Pedersen; Anne-Marie Nybo Andersen; Maria A Mansilla; Jeffrey C Murray; Kaare Christensen; Johnathan L Ballard; Elizabeth B Gorman; Robert M Cabrera; Richard H Finnell
Journal:  Pediatr Res       Date:  2010-03       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.